Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.2147/VHRM.S20181 http://scihub22266oqcxt.onion/10.2147/VHRM.S20181 21822394!3148420!21822394     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21822394&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Vasc+Health+Risk+Manag 2011 ; 7 (?): 467-74 Nephropedia Template TP {{tp|p=21822394|t=2011. Pre-eclampsia: pathophysiology, diagnosis, and management |pdf=|usr=}}{{21822394}} gab.com Text Pre-eclampsia: pathophysiology, diagnosis, and management JO: Vasc Health Risk Manag http://www.kidney.de/pget.php?&tw=1&pmid=21822394 #FOAvip The incidence of pre-eclampsia ranges from 3% to 7% for nulliparas and 1% to 3% for multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm birth, perinatal death, and intrauterine growth restriction. Unfortunately, the pathophysiology of this multisystem disorder, characterized by abnormal vascular response to placentation, is still unclear. Despite great polymorphism of the disease, the criteria for pre-eclampsia have not changed over the past decade (systolic blood pressure > 140 mmHg or diastolic blood pressure >/= 90 mmHg and 24-hour proteinuria >/= 0.3 g). Clinical features and laboratory abnormalities define and determine the severity of pre-eclampsia. Delivery is the only curative treatment for pre-eclampsia. Multidisciplinary management, involving an obstetrician, anesthetist, and pediatrician, is carried out with consideration of the maternal risks due to continued pregnancy and the fetal risks associated with induced preterm delivery. Screening women at high risk and preventing recurrences are key issues in the management of pre-eclampsia. Twit Text FOAVip Pre-eclampsia: pathophysiology, diagnosis, and management ????Vasc Health Risk Manag http://www.kidney.de/pget.php?&tw=1&pmid=21822394 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=21822394 #FOAvip English Wikipedia <ref>{{Cite pmid|21822394}}</ref> Pre-eclampsia: pathophysiology, diagnosis, and management #MMPMID21822394 Uzan J; Carbonnel M; Piconne O; Asmar R; Ayoubi JM Vasc Health Risk Manag 2011[]; 7 (?): 467-74 PMID21822394show ga The incidence of pre-eclampsia ranges from 3% to 7% for nulliparas and 1% to 3% for multiparas. Pre-eclampsia is a major cause of maternal mortality and morbidity, preterm birth, perinatal death, and intrauterine growth restriction. Unfortunately, the pathophysiology of this multisystem disorder, characterized by abnormal vascular response to placentation, is still unclear. Despite great polymorphism of the disease, the criteria for pre-eclampsia have not changed over the past decade (systolic blood pressure > 140 mmHg or diastolic blood pressure >/= 90 mmHg and 24-hour proteinuria >/= 0.3 g). Clinical features and laboratory abnormalities define and determine the severity of pre-eclampsia. Delivery is the only curative treatment for pre-eclampsia. Multidisciplinary management, involving an obstetrician, anesthetist, and pediatrician, is carried out with consideration of the maternal risks due to continued pregnancy and the fetal risks associated with induced preterm delivery. Screening women at high risk and preventing recurrences are key issues in the management of pre-eclampsia. |*Pre-Eclampsia/diagnosis/mortality/physiopathology/therapy[MESH] |Blood Pressure[MESH] |Delivery, Obstetric[MESH] |Female[MESH] |Humans[MESH] |Predictive Value of Tests[MESH] |Pregnancy[MESH] |Risk Assessment[MESH] |Risk Factors[MESH]Pre-eclampsia: pathophysiology, diagnosis, and management (epmc).pdf DeepDyve Pubget Overpricing